Forum Topic News
  • Conversation: US approves Janssen’s HIV pill Symtuza

    • July 18, 2018 12:06 PM BST
    • US approves Janssen’s HIV pill Symtuza

      Janssen’s Symtuza has been approved US regulators as the first and only complete, darunavir-based single-tablet regimen for the treatment of HIV in adults.
      According to Janssen, single table regimens have the capacity to boost adherence and reduce the medicine burden
      Symtuza darunavir (cobicistat/emtricitabine/tenofovir alafenamide) offers patients “the proven protective barrier to resistance of darunavir in a formulation designed for improved tolerability and the convenience,” it said.
      Read more: http://www.pharmatimes.com/news/us_approves_janssens_hiv_pill_symtuza_1244683

Add Reputation

Do you want to add reputation for this member by this post?

or cancel